GGrantIndex
← Search

PHASE II SAFETY AND IMMUNOGENICITY STUDY OF QUADRIVALENT HUMAN PAPILLOMAVIRUS

$10,725M01FY2007RRNIH

Baylor College Of Medicine, Houston TX

Investigators

Linked publications & trials

View original record on NIH RePORTER →